Trials / Completed
CompletedNCT01298843
Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital
Pharmacokinetics of a Single Dose of Ceftaroline Fosamil in Children Ages Birth to Younger Than 12 Years With Suspected or Confirmed Infection
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Forest Laboratories · Industry
- Sex
- All
- Age
- 11 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess blood levels of Ceftaroline fosamil in children.
Detailed description
To characterize single dose pharmacokinetics of Ceftaroline fosamil in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ceftaroline fosamil | Single dose of 15 mg/kg (up to 600 mg) by intravenous infusion |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2011-02-18
- Last updated
- 2014-05-14
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01298843. Inclusion in this directory is not an endorsement.